ALHC Alignment Healthcare, Inc.
Hospital & Medical Service Plans · Nasdaq · SEC CIK 1832466 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY35.9%
TTM net income YoY239.0%
TTM EPS YoY227.3%
Revenue 3-yr CAGR42.2%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin0.9%
Net margin0.6%
FCF margin1.6%
EBITDA margin1.5%
Returns
ROE13.2%
ROA2.4%
ROIC (approx.)—
Asset turnover4.12x
Leverage & solvency
Liabilities / assets78.6%
Debt / equity1.17x
Current ratio1.71x
Interest coverage2.63x
Cash quality & payout
Operating cash flow / net income3.74x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue0.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.95B | $2.70B | $1.82B | $1.43B | $1.17B |
| SG&A expense | $443.41M | $371.37M | $307.43M | $295.65M | $290.99M |
| Operating income | $14.75M | -$101.56M | -$127.82M | -$128.64M | -$178.07M |
| Interest expense | $15.80M | $23.55M | $21.23M | $18.29M | $17.44M |
| Pretax income | -$958,000 | -$128.05M | -$148.19M | -$149.30M | -$195.29M |
| Income tax | $20,000 | $21,000 | -$22,000 | $339,000 | $0 |
| Net income | -$724,000 | -$128.03M | -$148.02M | -$149.55M | -$195.29M |
| EBITDA | $45.16M | -$74.68M | -$106.40M | -$111.37M | -$162.26M |
| EPS (basic) | 0.00 | -0.67 | -0.79 | -0.83 | -1.14 |
| EPS (diluted) | 0.00 | -0.67 | -0.79 | -0.83 | -1.14 |
| Weighted avg. shares (diluted) | 198.01M | 190.79M | 186.21M | 181.21M | 181.92M |
| Balance sheet | |||||
| Cash & equivalents | $575.82M | $434.94M | $202.90M | $411.30M | $468.35M |
| Short-term investments | $28.41M | $37.79M | $115.91M | $0 | — |
| Receivables | $253.21M | $153.90M | $119.75M | $92.89M | $58.51M |
| Current assets | $951.58M | $661.64M | $483.54M | $544.55M | $552.86M |
| PP&E, net | $64.25M | $67.14M | $51.90M | $37.17M | $30.36M |
| Goodwill | $32.06M | $34.83M | $34.83M | $34.81M | $29.30M |
| Intangibles | $4.55M | $4.55M | $5.25M | $5.48M | $35.12M |
| Total assets | $1.07B | $782.06M | $591.88M | $633.86M | $630.89M |
| Current liabilities | $556.87M | $351.85M | $263.02M | $229.96M | $167.25M |
| Short-term debt | $0 | $0 | $0 | $0 | $0 |
| Long-term debt | $323.18M | $321.43M | $161.81M | $160.90M | $150.62M |
| Total debt | $323.18M | $321.43M | $161.81M | $160.90M | $150.62M |
| Total liabilities | $886.51M | $681.11M | $433.81M | $394.56M | $324.84M |
| Shareholders' equity | $179.28M | $99.85M | $156.95M | $238.13M | $306.04M |
| Net debt | -$252.64M | -$113.51M | -$41.09M | -$250.40M | -$317.73M |
| Shares outstanding | 204.15M | 191.78M | 188.95M | 187.28M | 187.19M |
| Cash flow statement | |||||
| Operating cash flow | $139.93M | $34.77M | -$59.19M | -$45.43M | -$78.78M |
| Capital expenditure | $26.78M | $41.42M | $35.99M | $23.77M | — |
| Free cash flow | $113.15M | -$6.65M | -$95.18M | -$69.20M | — |
| Investing cash flow | -$14.97M | $39.19M | -$147.26M | -$28.22M | -$20.82M |
| Financing cash flow | $18.04M | $156.03M | $105,000 | $16.59M | $360.13M |
| Depreciation & amortization | $30.40M | $26.87M | $21.41M | $17.27M | $15.81M |
| Stock-based compensation | $62.08M | $71.13M | $66.83M | $81.72M | $621,000 |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.